University of Colorado Cancer Center researchers recently completed the largest-ever study of thyroid cancer genetics, mining the data of 583 patient samples of advanced differentiated thyroid cancer and 196 anaplastic thyroid ...
Apr 26, 2018
0
384
A new study spanning 45 years has shown that while Alaska Natives have a similar incidence of thyroid cancer as the U.S. white population, their tumors at the time of diagnosis tend to be larger and to have spread beyond ...
Apr 11, 2018
0
3
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.
Mar 30, 2018
0
1588
A new cancer drug has proven safe and effective for pediatric patients with a rare tumor gene mutation, according to a study published today in The Lancet. The study tested the safety and dose of larotrectinib (LOXO-195) ...
Mar 30, 2018
0
5
Not all cancers are equal.
Mar 7, 2018
0
64
Three thyroid cancer treatments have been approved for routine use on the NHS in England.
Feb 26, 2018
0
2
Results of a new phase II clinical trial indicate that cabozantinib offers an active therapy option for patients with differentiated thyroid cancer (DTC) that has progressed following surgery and treatment with radioactive ...
Feb 13, 2018
0
1
Thyroid cancer is a disease with good cure rates in most cases. In 5 percent of patients, however, the tumor becomes refractory to the available therapies and may spread all over the body, causing death.
Jan 19, 2018
0
13
New lessons are being learned about risk assessment and predicting the extent of thyroid cancer occurrence following radiation exposure due to a nuclear power plant accident such as the one in March 2011 in Fukushima Prefecture ...
Dec 21, 2017
0
11
(HealthDay)—Lymph node density (LND) can help predict outcomes in patients with papillary thyroid cancer, according to a study published online Nov. 30 in JAMA Otolaryngology—Head & Neck Surgery .
Dec 5, 2017
0
0
